RecruitingNot Applicable

A Clinical Registry to Demonstrate the Safety and Performance of Teleflex Vascular Access Devices

United States2,500 participantsStarted 2024-12-08

Plain-language summary

The general objective of Teleflex's Vascular Access Device Registry (VADER) is to provide high-quality Level 3 (or better) data on the performance, safety and clinical benefits of Teleflex's vascular access devices when used in a real-world setting

Who can participate

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Subjects will undergo a procedure that will include use of a Teleflex device covered by this Research. * Subject is willing and capable of providing informed consent and/or give approval to collect, store and process limited health information by the Sponsor; or such consent is provided by a legally designated representative if required by local law or regulation. * Subjects is able to read and understand English or Spanish languages Exclusion Criteria: * Subject is currently participating in another clinical Registry or investigation that may confound the results of this Registry. * Subject was previously failed screening or was enrolled in this clinical Registry. * Subject is imprisoned * Subject is cognitively impaired and unable to provide informed consent

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Catheter devices: successful use of the device without removal due to device-related adverse events

Timeframe: Within 7 days after subject device removal

Arrow VPS Rhythm DXL catheter tip positioning system: Successful verification of catheter tip location

Timeframe: Immediately after subject device removal

Trial details

NCT IDNCT06604039

SponsorTeleflex

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2034-12-07

Contact for this trial

Samson Odeyemi

9402904684 samson.odeyemi@teleflex.com

View on ClinicalTrials.gov More Vascular Access Device trials